- QIAGEN partners with McGill University to enhance microbiome research, with McGill serving as a beta-testing site for QIAGEN’s new solutions.
- The collaboration focuses on DNA extraction and anaerobic culturing, aiming to strengthen QIAGEN’s presence in North America’s $1.8 billion microbiome market and support McGill’s training and research capabilities.
Tue Nov 12 22:10:07 -0000 2024 UTC– QIAGEN partners with McGill University for microbiome research projects to enhance understanding of microbial communities in medicine and public health.
McGill will test new QIAGEN solutions, aiding research efforts at the McGill Centre for Microbiome Research. This collaboration aims to advance microbiome science and develop innovative solutions.
The partnership also aligns with QIAGEN’s strategy to advance microbiome sciences, leveraging McGill’s infrastructure to push knowledge boundaries and improve health outcomes.